Editorial

Split Viewer

Blood Res 2013; 48(3):

Published online September 25, 2013

https://doi.org/10.5045/br.2013.48.3.165

© The Korean Society of Hematology

Fighting back against chronic myelomonocytic leukemia

Deog-Yeon Jo, M.D. Ph.D.

Department of Internal Medicine, School of Medicine, Chungnam National University, Daejeon, Korea.

This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.

REFERENCES

  1. Onida, F, Barosi, G, Leone, G, et al. Management recommendations for chronic myelomonocytic leukemia: consensus statements from the SIE, SIES, GITMO groups. Haematologica, 2013;98;1344-1352.
    Pubmed
  2. Breccia, M, Voso, MT, Alimena, G. Chronic myelomonocytic leukemia treatment with azacitidine: what have we learned so far?. Leuk Res, 2013;37;204-205.
    Pubmed
  3. Wijermans, PW, Ruter, B, Baer, MR, Slack, JL, Saba, HI, Lubbert, M. Efficacy of decitabine in the treatment of patients with chronic myelomonocytic leukemia (CMML). Leuk Res, 2008;32;587-591.
    Pubmed
  4. Onida, F, Kantarjian, HM, Smith, TL, et al. Prognostic factors and scoring systems in chronic myelomonocytic leukemia: a retrospective analysis of 213 patients. Blood, 2002;99;840-849.
    Pubmed
  5. Such, E, Germing, U, Malcovati, L, et al. Development and validation of a prognostic scoring system for patients with chronic myelomonocytic leukemia. Blood, 2013;121;3005-3015.
    Pubmed
  6. Park, S, Labopin, M, Yakoub-Agha, I, et al. Allogeneic stem cell transplantation for chronic myelomonocytic leukemia: a report from the Societe Francaise de Greffe de Moelle et de Therapie Cellulaire. Eur J Haematol, 2013;90;355-364.
    Pubmed
  7. Sun, YQ, Xu, LP, Liu, DH, et al. Allogeneic hematopoietic stem cell transplantation for chronic myelomonocytic leukemia: a report of 12 patients. Zhonghua Xue Ye Xue Za Zhi, 2013;34;113-116.
    Pubmed
  8. Lim, SN, Lee, JH, Lee, JH, et al. Allogeneic hematopoietic cell transplantation in adult patients with myelodysplastic/myeloproliferative neoplasms. Blood Res, 2013;48;178-184.

Article

Editorial

Blood Res 2013; 48(3): 165-166

Published online September 25, 2013 https://doi.org/10.5045/br.2013.48.3.165

Copyright © The Korean Society of Hematology.

Fighting back against chronic myelomonocytic leukemia

Deog-Yeon Jo, M.D. Ph.D.

Department of Internal Medicine, School of Medicine, Chungnam National University, Daejeon, Korea.

This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.

    References

    1. Onida, F, Barosi, G, Leone, G, et al. Management recommendations for chronic myelomonocytic leukemia: consensus statements from the SIE, SIES, GITMO groups. Haematologica, 2013;98;1344-1352.
      Pubmed
    2. Breccia, M, Voso, MT, Alimena, G. Chronic myelomonocytic leukemia treatment with azacitidine: what have we learned so far?. Leuk Res, 2013;37;204-205.
      Pubmed
    3. Wijermans, PW, Ruter, B, Baer, MR, Slack, JL, Saba, HI, Lubbert, M. Efficacy of decitabine in the treatment of patients with chronic myelomonocytic leukemia (CMML). Leuk Res, 2008;32;587-591.
      Pubmed
    4. Onida, F, Kantarjian, HM, Smith, TL, et al. Prognostic factors and scoring systems in chronic myelomonocytic leukemia: a retrospective analysis of 213 patients. Blood, 2002;99;840-849.
      Pubmed
    5. Such, E, Germing, U, Malcovati, L, et al. Development and validation of a prognostic scoring system for patients with chronic myelomonocytic leukemia. Blood, 2013;121;3005-3015.
      Pubmed
    6. Park, S, Labopin, M, Yakoub-Agha, I, et al. Allogeneic stem cell transplantation for chronic myelomonocytic leukemia: a report from the Societe Francaise de Greffe de Moelle et de Therapie Cellulaire. Eur J Haematol, 2013;90;355-364.
      Pubmed
    7. Sun, YQ, Xu, LP, Liu, DH, et al. Allogeneic hematopoietic stem cell transplantation for chronic myelomonocytic leukemia: a report of 12 patients. Zhonghua Xue Ye Xue Za Zhi, 2013;34;113-116.
      Pubmed
    8. Lim, SN, Lee, JH, Lee, JH, et al. Allogeneic hematopoietic cell transplantation in adult patients with myelodysplastic/myeloproliferative neoplasms. Blood Res, 2013;48;178-184.
    Blood Res
    Volume 59 2024

    Stats or Metrics

    Share this article on

    • line

    Blood Research

    pISSN 2287-979X
    eISSN 2288-0011
    qr-code Download